You are here: Welcome » Michael Callahan

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
michael_callahan [2023/03/02 19:31]
liam
michael_callahan [2023/07/05 21:14] (current)
liam
Line 5: Line 5:
 Dr. **Michael Callahan** is an American infectious diseases scientist. He is a staff physician at the [[Massachusetts General Hospital]] (MGH) and a clinical subject matter expert for international clinical trials for the [[Assistant Secretary of Public Health Preparedness]] (ASPR) of the [[United States Department of Health and Human Services ]] (HHS).((//Michael Callahan.// Vaccine & Immunotherapy Center. Retrieved March 2, 2023, from https://web.archive.org/web/20230302083941/https://advancingcures.org/vic-management-michael-callahan/)) Dr. **Michael Callahan** is an American infectious diseases scientist. He is a staff physician at the [[Massachusetts General Hospital]] (MGH) and a clinical subject matter expert for international clinical trials for the [[Assistant Secretary of Public Health Preparedness]] (ASPR) of the [[United States Department of Health and Human Services ]] (HHS).((//Michael Callahan.// Vaccine & Immunotherapy Center. Retrieved March 2, 2023, from https://web.archive.org/web/20230302083941/https://advancingcures.org/vic-management-michael-callahan/))
  
-He also maintains appointments at [[Harvard Medical School]] and [[King Chulalongkom Medical University]] in Bangkok, and consults for the [[National Academies of Sciences, Engineering and Medicine]], [[National Security Council]] (NSC), [[Biological Sciences Experts Group]] (BSEG), the [[Office of Net Assessment]] (ONA), [[National Institute of Allergy and Infectious Diseases]] (NIAID), [[Mitre]], the [[American Society of Microbiology]], [[Infectious Diseases Society of America]] (IDSA), and the ppAmerican Society of Tropical Medicine and Hygiene]].+He also maintains appointments at [[Harvard Medical School]] and [[King Chulalongkom Medical University]] in Bangkok, and consults for the [[National Academies of Sciences, Engineering and Medicine]], [[National Security Council]] (NSC), [[Biological Sciences Experts Group]] (BSEG), the [[Office of Net Assessment]] (ONA), [[National Institute of Allergy and Infectious Diseases]] (NIAID), [[Mitre]], the [[American Society of Microbiology]], [[Infectious Diseases Society of America]] (IDSA), and the [[American Society of Tropical Medicine and Hygiene]]. 
 + 
 +Callahan serves as President of Cellular Therapies at [[pharmaceutical_companies:United Therapeutics Corporation]].
  
 ===== History ===== ===== History =====
Line 15: Line 17:
 ==== Career ==== ==== Career ====
  
-In 2002, Callahan was appointed clinical director for [[Office of Cooperative Threat Reduction|Cooperative Threat Reduction]] programs at six former [[Soviet Union]] biological weapons institutes (including [[Vector Institute]], [[State Research Center for Applied Microbiology]], [[Scientific Research Institute of Microbiology]] and [[Research Center of Molecular Diagnostics & Therapy]]), which included redirecting of unanticipated dual use and [[gain-of-function]] programs.+In 2002, Callahan was appointed clinical director for [[Office of Cooperative Threat Reduction|Cooperative Threat Reduction]] programs at six former [[Soviet Union]] biological weapons institutes (including [[State Research Center of Virology and Biotechnology VECTOR]], [[State Research Center for Applied Microbiology]], [[Scientific Research Institute of Microbiology]] and [[Research Center of Molecular Diagnostics & Therapy]]), which included redirecting of unanticipated dual use and [[gain-of-function]] programs.
  
 === DARPA === === DARPA ===
Back to top